JPRN-UMIN000006128已完成2 期
Adoptive immunotherapy using zoledronate-expanded autologous gamma/delta T cells for patients with non-small cell lung cancer refractory to standard treatment. - Zoledronate-expanded autologous gamma/delta T cell therapy for NSCLC
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have: - Uncontrolled infections; - Active autoimmune diseases; - Serious cardiac disease; - Other cancers; - Received continuous systemic steroids; - Pregnant, to be pregnant, or nursing mothers; - Principle investigator or co-investigator judged to be inappropriate to participate in this study.
研究者
相似试验
招募中
1 期
Treatment with zoledronate subsequent to denosumab in osteoporosis 2OsteoporosisCTIS2022-502621-17-00Aarhus University Hospital1
进行中（未招募）
4 期
ow Dose Intravenous Zoledronate for the Treatment of Post-menopausal Osteoporosis: a prospective open-labeled studypostmenopausal osteoporosis, zoledronate, bone mineral density, fracture, preventionPostmenopausal osteoporosisTCTR20210930001Phramongkutklao hospital36
进行中（未招募）
1 期
A pilot study to investigate Zoledronic acid as a add on treatment in neovascular Age-related Macular Degeneratioeovascular Age-related Macular DegenerationMedDRA version: 20.0Level: PTClassification code 10071129Term: Neovascular age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersEUCTR2019-001492-37-NOOslo University Hospital40
招募中
2 期
Phase II study of neoadjuvant zoledronic acid therapy for early breast cancer patientsearly breast cancerJPRN-UMIN000003493Division of Medical Oncology and Breast Surgery, Cancer Institute Hospital30
进行中（未招募）
1 期
Short term biological study effects of Zoledronate and Letrozole on invasive breast cancer - Short term effects (preoperative) of Femara and Zometa or Femara aloneBreast CancerEUCTR2004-004223-36-GBSouth Manchester University Hospital110